Alpine Quantum Technologies

Alpine Quantum Technologies develops trapped ion quantum computers and quantum simulators based on research from the University of Innsbruck, offering cloud-accessible quantum systems through their AQT quantum cloud platform for research institutions and companies working on quantum algorithms, optimization problems, and quantum simulation applications in materials science and chemistry.

Company Information

• Founded: 2018
• Country: Austria
• Website: https://aqt.eu
• Categories: hardware, quantum algorithms, quantum chemistry, quantum cloud, quantum education, quantum materials, quantum optimization, quantum simulation, quantum software, trapped ion

Investment Information

• Status: private
• Total Raised: $23.2M
• Last Valuation: $150M

Recent Funding Rounds

• 2022-06-29: series-a - $19M - Series A funding round
• 2019-11-14: seed - $4.2M - Seed funding round

Related Companies

Explore other quantum computing companies in similar categories or regions.

Argonne National Laboratory

Argonne National Laboratory is a USA national laboratory founded July 1, 1946, located in Lemont, Illinois, operated by University of Chicago for United States Department of Energy. Argonne pursues research spanning theory, algorithms, simulations, and modeling of quantum systems leveraging supercomputing resources and multi-qubit hardware platforms. The laboratory operates quantum computing testbeds integrating quantum processors with high-performance computing infrastructure enabling hybrid quantum-classical algorithms. Argonne conducts quantum computing research across superconducting qubits, quantum algorithms, quantum networking, and quantum simulation applications. The laboratory is one of five DOE National Quantum Information Science Research Centers with over 1,500 experts collaborating across quantum research initiatives. Argonne serves scientific research community, government agencies, and industry partners requiring quantum computing applications in chemistry, materials science, optimization, and machine learning advancing quantum computational advantage for national security and energy applications.

BASF

BASF SE is a German multinational chemical company founded in 1865, headquartered in Ludwigshafen, Germany, largest chemical producer in the world. BASF explores quantum computing applications for computational chemistry including catalyst design, materials discovery, chemical process optimization, and molecular simulation. The company collaborates with quantum computing providers including IBM, Microsoft, and others developing quantum algorithms for chemical industry applications. BASF investigates quantum simulation for understanding chemical reactions and designing new materials with improved properties. The company serves global chemical industry requiring quantum-enhanced computational capabilities for materials science, process optimization, and product development. BASF advances quantum computing applications in chemistry demonstrating practical quantum advantage for chemical industry and materials science accelerating materials discovery and chemical process optimization through quantum technology.

Brookhaven National Laboratory

Brookhaven National Laboratory is a USA national laboratory founded in 1947, located in Upton, New York, operating under United States Department of Energy. Brookhaven leads Co-design Center for Quantum Advantage (C2QA), one of five DOE National Quantum Information Science Research Centers established in 2020, directed by Andrew Houck. C2QA brings together experts to co-design quantum hardware, software, and algorithms to achieve quantum advantage. The laboratory conducts quantum computing research spanning superconducting qubits, quantum algorithms, quantum networking, and quantum sensors. Brookhaven operates quantum computing testbeds and collaborates with over 1,500 experts across 115 academic, industry, and national science institutions. The laboratory serves quantum computing research community, government agencies, and industry partners requiring fundamental quantum research, quantum algorithm development, and quantum hardware co-design advancing towards practical quantum advantage for scientific applications in physics, chemistry, materials science, and national security.

Classiq

Classiq has revolutionized quantum software development with its groundbreaking platform that automatically synthesizes high-level functional models into optimized quantum circuits. Founded in 2020 by Nir Minerbi, Yehuda Naveh, and Amir Naveh, the company addresses one of quantum computing’s biggest challenges: translating complex algorithms into efficient quantum circuits. Classiq’s platform uses advanced synthesis algorithms to automatically generate, optimize, and analyze quantum circuits, dramatically reducing development time from months to days. The platform supports multiple quantum hardware backends and integrates with existing quantum development frameworks, enabling developers to focus on algorithm logic rather than low-level circuit optimization. In May 2025, Classiq raised $110 million in Series C funding, the largest ever for a quantum software company. In October 2025, Classiq was named to Fast Company’s annual Next Big Things in Tech list in the Computing, Chips and Foundational Technology category for transforming how organizations produce software for quantum computers, with Classiq technology being used by dozens of global enterprises and at over 400 universities. In October 2025, Comcast launched a quantum lab and began trials using quantum computing to improve broadband network management, partnering with D-Wave and Classiq to test applications such as traffic optimization and predictive issue resolution. Classiq has secured significant funding and partnerships with quantum hardware companies, cloud providers, and research institutions. Their technology has been adopted by organizations ranging from startups to Fortune 500 companies working on quantum applications in finance, chemistry, optimization, and machine learning. As quantum computers scale toward practical applications, Classiq’s software synthesis approach becomes increasingly critical for unlocking quantum advantage.

CreativeQuantum

CreativeQuantum provides quantum mechanics-based R&D services for chemical and pharmaceutical industries. The Leverkusen company offers quantum chemistry consulting. CreativeQuantum helps chemical and pharmaceutical companies apply quantum mechanical simulation methods to accelerate R&D, improve product development, and solve complex molecular modeling challenges in materials science and drug discovery.

Company Information

• Founded: 2016
• Country: Germany
• Website: https://creative-quantum.eu
• Categories: quantum chemistry, consulting

Related Companies

Explore other quantum computing companies in similar categories or regions.

FeNNix

FeNNix-Bio1 is a quantum AI foundation model developed by Qubit Pharmaceuticals and Sorbonne University that transforms molecular simulations across biomolecular and pharmaceutical research. Trained entirely on synthetic quantum chemistry data, FeNNix-Bio1 integrates high-accuracy quantum methods including Density Functional Theory (DFT), Quantum Monte Carlo (QMC), and Configuration Interaction (CI) to build comprehensive generalizable representation of interatomic forces. Development enabled by exascale high-performance computing resources from GENCI, EuroHPC, and Argonne. Can be trained in few hours using standard GPU whereas other AI models require weeks of supercomputing time. Enables reactive molecular dynamics simulations at scale and accuracy previously unattainable, including formation and breaking of chemical bonds, proton transfer, and quantum nuclear effects. Applications extend beyond pharmaceuticals to industrial enzymes, desalination membranes, next-generation batteries, and green chemistry. Qubit Pharmaceuticals based in Paris and Boston with team over 60 people from 18+ nationalities.

Good Chemistry

Good Chemistry Company is an American quantum software company founded in 2020 developing quantum computing applications for computational chemistry and materials science. The company provides quantum algorithms and software platforms for molecular simulation, drug discovery, catalyst design, and materials discovery. Good Chemistry focuses on near-term quantum advantage for chemistry applications using hybrid quantum-classical algorithms. The company collaborates with pharmaceutical companies, chemical manufacturers, and materials science researchers developing practical quantum applications for industrial chemistry. Good Chemistry serves pharmaceutical industry, chemical companies, materials science organizations, and research institutions requiring quantum-enhanced computational chemistry capabilities. The company advances quantum computing applications in drug discovery and materials design demonstrating practical quantum advantage for chemistry and materials science advancing quantum technology commercialization in chemical and pharmaceutical industries.

Harvard University

Harvard University is a private Ivy League research university founded 1636 in Cambridge Massachusetts. Central to Harvard quantum initiatives is Harvard Quantum Initiative uniting researchers from various disciplines to advance quantum science and engineering. In September 2025, a team of Harvard physicists led by Mikhail Lukin (Joshua and Beth Friedman University Professor) achieved a historic breakthrough by building the first quantum computer that can operate continuously for over 2 hours without restarting, published in Nature. The system operates an array of more than 3,000 qubits (neutral atoms) and theoretically could continue indefinitely, representing a massive improvement over existing quantum computers that typically run for milliseconds or at most 13 seconds. The breakthrough was achieved by replenishing qubits in real time, injecting new atoms at a rate of 300,000 per second using an optical lattice conveyor belt system to counteract atom loss and maintain quantum information, with over 50 million atoms cycled through the system during the two-hour demonstration. This transformative achievement demonstrates that quantum computers capable of running forever in practice are now just three years away (down from five+ years previously), marking a critical milestone toward practical, continuously operating quantum computing systems. Harvard Quantum Initiative is one of strongest in country heavily focused on quantum networking quantum chemistry and quantum materials research. Harvard conducts quantum research spanning quantum processors quantum algorithms quantum communication networks quantum simulation and quantum sensing. The university maintains partnerships with leading quantum companies including QuEra Computing and government agencies. Harvard serves quantum research community through fundamental quantum research quantum education programs and technology transfer advancing quantum information science and quantum technology commercialization supporting USA quantum leadership.

IonQ

In 2024-2025, IonQ raised approximately $372.6 million through an at-the-market equity offering (announced March 10, 2025), bringing the company’s cash balance to over $700 million. The company secured a major contract with Korea Institute of Science and Technology Information (KISTI) in July 2025 to deliver a 100-qubit quantum system for South Korea’s first National Quantum Computing Centre of Excellence. IonQ also signed a Memorandum of Understanding with Japan’s AIST to provide access to IonQ’s Forte-class quantum computers. At Quantum World Congress 2025, IonQ announced a groundbreaking advancement in quantum chemistry simulations with its quantum-classical auxiliary-field quantum Monte Carlo (QC-AFQMC) algorithm, demonstrating unprecedented precision in computing atomic-level forces with potential applications in drug discovery and climate change solutions. On October 7, 2025, IonQ completed the acquisition of Vector Atomic, a California-based quantum sensing company, in an all-stock transaction. The acquisition brought 75+ employees, scientists, engineers, and operators to IonQ, along with precision atomic clocks, inertial sensors, gravimeters, and synchronization hardware technology. Vector Atomic secured over $200 million in government contracts and holds 29 pending and issued patents in quantum sensing and timing. The acquisition expands IonQ’s portfolio from quantum computing into quantum sensing, timing, and navigation markets, with Vector Atomic’s technology delivering 1,000x improvement in GPS accuracy and picosecond-level timing precision for defense, aerospace, and commercial applications.

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical and medical technologies corporation founded in 1886, with Janssen Pharmaceuticals subsidiary launching three-year research collaboration with Qu&Co in 2021 to develop and test quantum computational algorithms and software for pharmaceutical R&D applications. Janssen employed Qu&Co’s QUBEC platform for quantum computational chemistry and materials science, testing algorithms on quantum processors. In 2024, Johnson & Johnson partnered with Pasqal working to demonstrate practical benefits of quantum computing for drug discovery problems. Johnson & Johnson is among biggest pharma industry players submitting quantum computing patents alongside Merck, Roche, and Amgen. The company uses quantum computing for molecular simulations, optimization problems in drug discovery, and computational chemistry applications. Johnson & Johnson serves global pharmaceutical market requiring quantum-enhanced drug discovery, molecular modeling, and computational chemistry for developing treatments for cancer, Alzheimer’s, Parkinson’s, and other conditions accelerating path from discovery to clinical trials.

Kuano London

Kuano uses quantum simulation and quantum-inspired AI for enzyme drug design with programs in epigenetics, protein degradation, and infectious disease. The London company develops quantum-enhanced drug discovery platforms. Kuano combines quantum algorithms with machine learning to accelerate enzyme engineering and drug design, targeting challenging therapeutic areas where conventional computational methods provide limited insights.

Company Information

• Founded: 2020
• Country: United Kingdom
• Website: https://kuano.ai
• Categories: quantum chemistry, drug discovery

Related Companies

Explore other quantum computing companies in similar categories or regions.

Lawrence Berkeley National Laboratory

Lawrence Berkeley National Laboratory (Berkeley Lab) is a USA national laboratory founded August 26, 1931, located in Berkeley, California, operated by University of California for United States Department of Energy. Berkeley Lab leads Quantum Systems Accelerator (QSA), one of five DOE National Quantum Information Science Research Centers bringing together 80 world-class researchers from 15 partner institutions. QSA catalyzes national leadership in quantum information science to co-design algorithms, quantum devices, and engineering solutions delivering certified quantum advantage in scientific applications. The laboratory conducts quantum computing research spanning quantum processors, quantum algorithms, quantum networking, quantum sensors, and quantum materials. Berkeley Lab operates quantum computing testbeds and advanced characterization facilities for quantum hardware development. The laboratory serves quantum research community collaborating with universities, industry, and government agencies advancing quantum computing for energy, chemistry, materials science, and national security applications requiring quantum computational advantage.

Menten AI Canada

Menten AI is a software platform for protein design powered by machine learning and quantum computing, improving drug discovery accuracy while reducing costs. The Toronto company applies quantum computing to protein engineering. Menten AI uses quantum annealing and machine learning to design novel protein therapeutics, addressing challenges in biologics development and potentially accelerating the discovery of protein-based drugs.

Company Information

• Founded: 2018
• Country: Canada
• Website: https://menten.ai
• Categories: quantum chemistry, protein design

Related Companies

Explore other quantum computing companies in similar categories or regions.

Novartis

Novartis AG is a Swiss multinational pharmaceutical corporation founded in 1996 (through merger of Ciba-Geigy and Sandoz), headquartered in Basel, Switzerland. Novartis explores quantum computing applications for drug discovery including molecular simulation, protein folding, drug-target interaction modeling, and pharmaceutical development. The company collaborates with quantum computing providers and quantum software companies developing quantum algorithms for computational drug discovery. Novartis investigates quantum machine learning for analyzing pharmaceutical data and quantum simulation for understanding complex biological molecules. The company serves global pharmaceutical industry requiring quantum-enhanced computational capabilities for drug discovery and development. Novartis advances quantum computing applications in pharmaceutical research demonstrating practical quantum applications for healthcare and drug discovery accelerating pharmaceutical development through quantum technology and quantum-enhanced computational chemistry.

NVIDIA

NVIDIA provides quantum computing services and infrastructure through their CUDA Quantum platform and DGX Quantum systems that enable hybrid quantum-classical computing by combining quantum processors with NVIDIA’s GPU-accelerated computing platform, offering quantum simulation capabilities, quantum circuit optimization, and quantum machine learning tools that leverage classical GPU computing to enhance quantum algorithm development and execution across various quantum hardware platforms. In September 2025, NVIDIA announced the establishment of its NVIDIA Advanced Quantum Computing (NVAQC) research center in Boston, Massachusetts, focused on advancing hybrid quantum-classical algorithms, quantum error mitigation techniques, and GPU-accelerated quantum simulation for drug discovery and materials science applications, strengthening NVIDIA’s quantum computing ecosystem partnerships with leading quantum hardware providers.

Oak Ridge National Laboratory

In 2024-2025, Oak Ridge National Laboratory achieved several major quantum computing milestones. In September 2025, Riverlane’s Deltaflow 2 real-time quantum error correction system was installed at ORNL, marking the first dedicated real-time QEC integration at a U.S. national laboratory. Also in September 2025, ORNL and Australian-German company Quantum Brilliance inaugurated the United States’ first on-site commercial quantum-computer cluster, the first of its kind to integrate a diamond-based quantum processor into a high-performance computing (HPC) environment. On August 29, 2025, ORNL released a comprehensive study outlining software architecture designed to integrate quantum computers with the world’s fastest supercomputers, notably the exascale machine Frontier. In November 2024, ORNL added IQM Resonance quantum cloud service to its Quantum Computing User Program. In August 2025, ORNL researchers developed a quantum microscope for nanoscale imaging and a multihop quantum network integrating with fibre-optic infrastructure. These developments demonstrate ORNL’s leadership in quantum-HPC integration.

Pasqal

In June 2024, Pasqal achieved a significant milestone by successfully loading over 1,000 atoms in a single shot, trapping more than 1,110 atoms within approximately 2,000 traps, demonstrating the feasibility of large-scale neutral atom quantum computing. In December 2024, Pasqal deployed a 100-qubit neutral atom quantum computer at the Jülich Supercomputing Centre in Germany as part of the HPCQS project, expected to be available for use by June 2025. On May 13, 2025, Pasqal partnered with Google Cloud to offer its 100-qubit QPU on Google Cloud Marketplace, including tools for workflow integration and post-processing results with a flexible pay-as-you-go model. Pasqal’s roadmap targets 10,000 qubits by 2026, and in April 2024, the company partnered with Welinq to achieve projected 10,000-qubit QPUs with high-fidelity two-qubit gates in the 2026-2027 timeframe. The company is already delivering quantum computers with over 100 qubits to end users.

Promethium

Promethium is QC Ware’s new software-as-a-service (SaaS) quantum chemistry platform introduced in April 2024 that promises to significantly speed up discovery processes in pharmaceutical, chemical, and material sectors. The platform provides quantum-enhanced computational chemistry tools for molecular simulation, drug discovery, and materials design. Promethium combines quantum algorithms with classical computational chemistry methods to achieve more accurate and faster molecular property predictions. The platform targets researchers and companies developing new drugs, catalysts, and advanced materials. QC Ware’s Promethium platform is cloud-based, providing easy access to quantum chemistry capabilities without requiring specialized quantum computing expertise. The software integrates with existing computational chemistry workflows and provides validation against experimental data. QC Ware, founded in 2014 and headquartered in Mountain View, California, specializes in enterprise quantum applications.

PsiQuantum

In September 2025, PsiQuantum announced the closing of a $1 billion Series E funding round, valuing the company at $7 billion and enabling construction of utility-scale quantum sites in Brisbane, Australia, and Chicago, United States. The round was led by affiliates of BlackRock and backed by Temasek, Baillie Gifford, Macquarie Capital, Ribbit Capital, NVentures, Adage Capital Management, the Qatar Investment Authority, Type One Ventures, Counterpoint Global, 1789 Capital and S Ventures. The company secured significant funding from the Australian and Queensland governments in 2024 to build the world’s first utility-scale, fault-tolerant quantum computer in Brisbane with target completion by the end of 2027. In February 2025, DARPA selected PsiQuantum to advance to the final phase of its Utility-Scale Quantum Computing Program. On April 15, 2025, PsiQuantum secured a $10.8 million contract with the Air Force Research Laboratory (AFRL). The company is now breaking ground on major facilities in both Chicago and Brisbane, building million-qubit scale fault-tolerant quantum computers using high-volume manufacturing of integrated photonic chips and 300 mm wafers produced at GlobalFoundries Fab 8 in New York.

QDX Computing

QDX is a computational drug discovery platform powered by quantum mechanics. Co-founded by Giuseppe M. J. Barca (Associate Professor, University of Melbourne, nominated by The Australian as one of Australia’s Top 250 Researchers in 2024) and Loong Wang (entrepreneur whose first two tech companies were valued at nearly $2 billion when sold) in 2023. Company specializes in high-performance quantum simulations to accelerate new therapeutics design. Has Canberra office on ANU campus and locations in Singapore. Self-funded startup seeking to close dedicated fundraise to scale Rush platform. Less than a year after incorporating, closed commercial deals with pharmaceutical companies and tech start-ups in Australia, Singapore, and the United States. Using high-performance quantum simulations currently being used to accelerate new therapeutics design. Employs several graduates of ANU School of Computing.

QIDO Platform

QIDO Platform (Quantum-Integrated Discovery Orchestrator) is a partnership between Mitsui, Quantinuum, and QSimulate for drug and materials discovery targeting catalysts, enzymes, batteries, and reaction mechanisms. The collaborative platform integrates quantum computing into discovery workflows. QIDO represents a major industrial initiative to apply quantum computing to materials science and drug development challenges with commercial and scientific value.

Company Information

• Founded: 2025
• Country: Japan
• Website: N/A
• Categories: quantum chemistry, quantum platform

Related Companies

Explore other quantum computing companies in similar categories or regions.

Quantinuum

In 2024-2025, Quantinuum achieved several historic milestones with its H-series quantum computers. The company surpassed a quantum volume of one million (1,048,576 or 2^20) and later achieved 33.5 million, surpassing competitors by a factor of 16,000. Quantinuum achieved ’three 9’s’ (99.9%) 2-qubit gate fidelity in its commercial quantum computer. In collaboration with Microsoft, the company demonstrated the most reliable logical qubits to date, with error rates 800 times lower than corresponding physical circuit error rates, advancing Quantinuum’s System Model H2 to Microsoft’s Level 2—Resilient phase of quantum computing. With JPMorgan Chase, Quantinuum achieved a 100x improvement over existing industry benchmarks using the H2-1 quantum computer with 56 trapped-ion qubits, setting a new world record for the cross entropy benchmark. The company announced its next system, Helios, set to launch in 2025 with 96 qubits and enhanced computational capabilities expected by mid-2025. In August 2025, Quantinuum raised approximately $400 million in a Series B funding round at a valuation of $10 billion. The round included a $50 million investment from Quanta at $26.76 per share, marking a major milestone in quantum computing financing. This Series B positions Quantinuum as one of the highest-valued quantum computing companies globally and provides capital to advance the development of the Helios system and expand commercial quantum computing services.

Quantistry

Quantistry is a Berlin-based quantum chemistry startup founded in 2018 by Dr. Marcel Quennet, Dr. Vincent Pohl, Arturo Robertazzi, and Stefan Kupferberg as a spin-off from Freie Universität Berlin. The company developed QuantistryLab, a cloud-based holistic computational platform integrating quantum technologies, physics-based simulations, and machine learning for chemical R&D and materials discovery. In March 2024, Quantistry secured €3 million in funding led by Ananda Impact Ventures, with co-investors including Chemovator (BASF’s business incubator), IBB Ventures, and a Family Office. The platform leverages quantum-based simulations, multiscale modeling, and AI-driven insights to accelerate the discovery and design of innovative sustainable materials including next-generation batteries, polymers, alloys, and carbon capture technologies. QuantistryLab provides access to over 100 million molecular and material structures where users can run their own quantum chemistry simulations combining expert knowledge and computing power in a complete cloud package, serving pharmaceutical, chemical, and materials science industries.

Quantum Intelligence Corp

Quantum Intelligence Corp (QIC) is a global leader in integrating quantum computing with artificial intelligence to innovate drug discovery. Their QUEST platform uses algorithms that analyze how electronic charges are distributed in molecules to predict drug behavior, effectiveness, and safety. The platform uses an Artificial Neural Network-based prediction model adopting 3D distribution of electrostatic potentials (ESPs) derived from quantum mechanics. In August 2024, QIC partnered with QuEra Computing to utilize quantum computers to boost QUEST platform performance. QIC collaborates with Oxford Quantum Circuits (UK), Quandela (France), Classiq (Israel), and has a joint venture with 48Hour Discovery (Canada). Beyond healthcare, QIC explores quantum computing applications in finance including algorithmic trading, risk analysis, and asset management.

QuantumLeap AI

QuantumLeap AI develops quantum machine learning software and AI-powered quantum algorithm optimization tools. The company combines quantum computing with classical AI to create hybrid systems for complex data analysis and pattern recognition. QuantumLeap AI’s platform provides tools for quantum neural network development, quantum feature extraction, and quantum-enhanced AI model training. Target applications include drug discovery, materials science, and financial modeling where quantum machine learning can provide advantages. Based in London, QuantumLeap AI collaborates with AI researchers and quantum computing companies. The company focuses on practical quantum machine learning applications deliverable on near-term quantum hardware. QuantumLeap AI offers both software tools and consulting services for quantum AI development.

QUDORA

QUDORA is a German quantum computing developer specializing in trapped-ion quantum computers using Near-Field Quantum Control (NFQC) technology. The company’s flagship NFQC technology relies on ions confined in electromagnetic traps and manipulated with finely tuned laser pulses, enabling room-temperature operation that reduces infrastructure costs compared to superconducting circuits requiring millikelvin temperatures. QUDORA’s compact, scalable architecture allows dozens of ions to be entangled in a single chip-scale module to create fault-tolerant quantum processors capable of running complex algorithms in minutes with cloud-based workflow compatibility. In September 2025, QUDORA announced a strategic collaboration with South Korean research institutions and technology partners to establish quantum computing research centers in Seoul and Daejeon, focusing on quantum applications for advanced materials, battery technology, and semiconductor manufacturing, positioning South Korea as a key market for QUDORA’s Asia-Pacific expansion strategy. In October 2025, QUDORA closed a strategic partnership with Kensho, a Taiwanese distributor, to accelerate quantum computing commercialization in Taiwan, combining QUDORA’s trapped-ion platform with Kensho’s deep ties to Taiwan’s precision-manufacturing sector to bring quantum-enhanced tools into laboratories, factories, and corporate data centers across Asia-Pacific. The alliance generated significant attention at SEMICON Taiwan 2025, targeting applications in semiconductor design, pharmaceutical research, and industrial optimization while expanding QUDORA’s presence beyond Europe into the strategically important Asia-Pacific market.

Qunova Computing Korea

Qunova Computing is the first company to achieve chemical accuracy on commercial quantum computing using platform-agnostic algorithms, focusing on drug discovery and materials science. The Daejeon-based company develops quantum chemistry algorithms. Qunova’s achievement of chemical accuracy represents a significant milestone in quantum computing applications for computational chemistry, demonstrating that current quantum hardware can deliver useful results for drug discovery and materials design applications.

Company Information

• Founded: 2021
• Country: Korea, South
• Website: https://qunova.ai
• Categories: quantum software, quantum chemistry

Related Companies

Explore other quantum computing companies in similar categories or regions.